Clinical impact of a highly prevalent Pseudomonas aeruginosa clone in Dutch cystic fibrosis patients

By de Vrankrijker A. M. M.   Brimicombe R. W.   Wolfs T. F. W.   Heijerman H. G. M.   van Mansfeld R.   van Berkhout F. T.   Willems R. J. L.   Bonten M. J. M.   van der Ent C. K.  

Clinical Microbiology & Infection, Vol. 17, Iss. 3, 2011-03 ,pp. : 382-385

Blackwell Publishing

Access to resources Recommend Favorite

Activity of the new cephalosporin CXA-101 (FR264205) against Pseudomonas aeruginosa isolates from chronically-infected cystic fibrosis patients

By Zamorano L.   Juan C.   Fernández-Olmos A.   Ge Y.   Cantón R.   Oliver A.  

Clinical Microbiology & Infection, Vol. 16, Iss. 9, 2010-09 ,pp. : 1482-1487

Blackwell Publishing

Access to resources Recommend Favorite

Stationary biofilm growth normalizes mutation frequencies and mutant prevention concentrations in Pseudomonas aeruginosa from cystic fibrosis patients

By García-Castillo M.   del Campo R.   Baquero F.   Morosini M.-I.   Turrientes M.-C.   Zamora J.   Cantón R.  

Clinical Microbiology & Infection, Vol. 17, Iss. 5, 2011-05 ,pp. : 704-711

Blackwell Publishing

Access to resources Recommend Favorite

Nosocomial outbreak of VIM-2 metallo-&bgr;-lactamase-producing Pseudomonas aeruginosa associated with retrograde urography

By Elias J.   Schoen C.   Heinze G.   Valenza G.   Gerharz E.   Riedmiller H.   Vogel U.  

Clinical Microbiology & Infection, Vol. 16, Iss. 9, 2010-09 ,pp. : 1494-1500

Blackwell Publishing

Access to resources Recommend Favorite

Resistance of Pseudomonas aeruginosa to Liquid Disinfectants on Contaminated Surfaces before Formation of Biofilms

By Sagripanti Jose-Luis   Bonifacino Aylin  

Journal of AOAC International, Vol. 83, Iss. 6, 2000-11 ,pp. : 1415-1422

AOAC International

Access to resources Recommend Favorite